Skip to main content
. 2014 Jun 14;5(16):6976–6982. doi: 10.18632/oncotarget.2106

Figure 3. Mice with Ptprd loss and Cdkn2a deletion develop lymphomas, histiocytic sarcomas, and soft tissue sarcomas.

Figure 3

(A) Number of tumor types (lymphoma, histiocytic sarcoma, soft tissue sarcoma, or bronchiolar/alveolar carcinoma) per mouse of each genotype. (B) Frequency of tumor types by genotype. Ptprd+/+Cdkn2a−/− (n=12), Ptprd+/−Cdkn2a−/− (n=20), and Ptprd−/−Cdkn2a−/− (n=8) mice. *Ptprd−/−Cdkn2a−/− vs. Ptprd+/+Cdkn2a9−/− lymphomas p<0.05; *with bracket, Ptprd−/−Cdkn2a−/− histiocytic sarcomas vs. soft tissue sarcoma p<0.05.